Tissue engineering for post-myocardial infarction ventricular remodeling

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 3, 2011, Pages 263-270

  Kolettis, T M ^a   Vilaeti, A ^a   Dimos, K ^b   Tsitou, N ^a   Agathopoulos, S ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Biomaterial scaffold; Cardiac repair; Heart failure; Myocardial infarction; Ventricular remodeling

Indexed keywords

BIOMATERIAL; GELATIN; GROWTH FACTOR; NANOFIBER; POLYPROPYLENE;

ARTICLE; CELL ADHESION; CELL TRANSPLANTATION; EXTRACELLULAR MATRIX; HEALING; HEART HYPERTROPHY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; MITRAL VALVE REGURGITATION; MYOBLAST; NONHUMAN; POST MYOCARDIAL INFARCTION VENTRICULAR REMODELLING; SURGICAL EQUIPMENT; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; GELATIN; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NANOFIBERS; TISSUE ENGINEERING; VENTRICULAR REMODELING;

EID: 79953773919     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955711795049853     Document Type: Article

References (73)

1. Jessup M.; Brozena, S. Heart failure. N. Engl. J. Med., 2003, 348, 2007-2018.
2. Sutton M.G.; Sharpe, N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation, 2000, 101, 2981-2988.
3. Sun Y.; Weber, K.T. Infarct scar: a dynamic tissue. Cardiovasc. Res., 2000, 46, 250-256.
4. St John Sutton M.; Lee, D.; Rouleau, J.L.; Goldman, S.; Plappert, T.; Braunwald, E.; Pfeffer, M.A. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation, 2003, 107, 2577-2582.
5. Mitsi A.C.; Hatzistergos, K.; Baltogiannis, G.G.; Kolettis, T.M. Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction. Med. Hypotheses, 2005, 64, 582-585.
6. Mitsi A.C.; Hatzistergos, K.E.; Niokou, D.; Pappa, L.; Baltogiannis, G.G.; Tsalikakis, D.G.; Papalois, A.; Kyriakides, Z.S.; Malamou-Mitsi, V.; Kolettis, T.M. Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction. Growth Horm. IGF Res., 2006, 16, 93-100.
7. Hatzistergos K.E.; Mitsi, A.C.; Zachariou, C.; Skyrlas, A.; Kapatou, E.; Agelaki, M.G.; Fotopoulos, A.; Kolettis, T.M.; Malamou-Mitsi, V. Randomised comparison of growth hormone versus IGF-1 on early post-myocardial infarction ventricular remodelling in rats. Growth Horm. IGF Res., 2008, 18, 157-165.
8. Elaiopoulos D.A.; Tsalikakis, D.G.; Agelaki, M.G.; Baltogiannis, G.G.; Mitsi, A.C.; Fotiadis, D.I.; Kolettis, T.M. Growth hormone decreases phase II ventricular tachyarrhythmias during acute myocardial infarction in rats. Clin. Sci. (Lond.), 2007, 112, 385-391.
9. Zhang M.; Methot, D.; Poppa, V.; Fujio, Y.; Walsh, K.; Murry, C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell Cardiol., 2001, 33, 907-921.
10. Kolettis T.M. Arrhythmogenesis after cell transplantation postmyocardial infarction. Four burning questions--and some answers. Cardiovasc. Res., 2006, 69, 299-301.
11. Agathopoulos S.; Tulyaganov, D.U.; Marques, P.A.; Ferro, M.C.; Fernandes, M.H.; Correia, R.N. The fluorapatite-anorthite system in biomedicine. Biomaterials, 2003, 24, 1317-1331.
12. Kelley S.T.; Malekan, R.; Gorman, J.H., 3rd; Jackson, B.M.; Gorman, R.C.; Suzuki, Y.; Plappert, T.; Bogen, D.K.; Sutton, M.G.; Edmunds, L.H., Jr. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation, 1999, 99, 135-142.
13. Moainie S.L.; Guy, T.S.; Gorman, J.H., 3rd; Plappert, T.; Jackson, B.M.; St John-Sutton, M.G.; Edmunds, L.H., Jr.; Gorman, R.C. Infarct restraint attenuates remodeling and reduces chronic ischemic mitral regurgitation after postero-lateral infarction. Ann. Thorac. Surg., 2002, 74, 444-449; discussion 449.
14. Enomoto Y.; Gorman, J.H., 3rd; Moainie, S.L.; Jackson, B.M.; Parish, L.M.; Plappert, T.; Zeeshan, A.; St John-Sutton, M.G.; Gorman, R.C. Early ventricular restraint after myocardial infarction: extent of the wrap determines the outcome of remodeling. Ann. Thorac. Surg., 2005, 79, 881-887; discussion 881-887.
15. Pilla J.J.; Blom, A.S.; Brockman, D.J.; Ferrari, V.A.; Yuan, Q.; Acker, M.A. Passive ventricular constraint to improve left ventricular function and mechanics in an ovine model of heart failure secondary to acute myocardial infarction. J. Thorac. Cardiovasc. Surg., 2003, 126, 1467-1476.
16. Saavedra W.F.; Tunin, R.S.; Paolocci, N.; Mishima, T.; Suzuki, G.; Emala, C.W.; Chaudhry, P.A.; Anagnostopoulos, P.; Gupta, R.C.; Sabbah, H.N.; Kass, D.A. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J. Am. Coll. Cardiol., 2002, 39, 2069-2076.
17. Fujimoto K.L.; Tobita, K.; Merryman, W.D.; Guan, J.; Momoi, N.; Stolz, D.B.; Sacks, M.S.; Keller, B.B.; Wagner, W.R. An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J. Am. Coll. Cardiol., 2007, 49, 2292-2300.
18. Franco-Cereceda A.; Lockowandt, U.; Olsson, A.; Bredin, F.; Forssell, G.; Owall, A.; Runsio, M.; Liska, J. Early results with cardiac support device implant in patients with ischemic and nonischemic cardiomyopathy. Scand. Cardiovasc. J., 2004, 38, 159-163.
19. Olsson A.; Bredin, F.; Franco-Cereceda, A. Echocardiographic findings using tissue velocity imaging following passive containment surgery with the Acorn CorCap cardiac support device. Eur. J. Cardiothorac. Surg., 2005, 28, 448-453.
20. Zimmermann W.H.; Eschenhagen, T. Cardiac tissue engineering for replacement therapy. Heart Fail Rev., 2003, 8, 259-269.
21. Kofidis T.; de Bruin, J.L.; Hoyt, G.; Ho, Y.; Tanaka, M.; Yamane, T.; Lebl, D.R.; Swijnenburg, R.J.; Chang, C.P.; Quertermous, T.; Robbins, R.C. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J. Heart Lung Transplant., 2005, 24, 737-744.
22. Zimmermann W.H.; Didie, M.; Wasmeier, G.H.; Nixdorff, U.; Hess, A.; Melnychenko, I.; Boy, O.; Neuhuber, W.L.; Weyand, M.; Eschenhagen, T. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation, 2002, 106, I151-157.
23. Kellar R.S.; Shepherd, B.R.; Larson, D.F.; Naughton, G.K.; Williams, S.K. Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. Tissue Eng., 2005, 11, 1678-1687.
24. Krupnick A.S.; Kreisel, D.; Engels, F.H.; Szeto, W.Y.; Plappert, T.; Popma, S.H.; Flake, A.W.; Rosengard, B.R. A novel small animal model of left ventricular tissue engineering. J. Heart Lung Transplant., 2002, 21, 233-243.
25. Miyahara Y.; Nagaya, N.; Kataoka, M.; Yanagawa, B.; Tanaka, K.; Hao, H.; Ishino, K.; Ishida, H.; Shimizu, T.; Kangawa, K.; Sano, S.; Okano, T.; Kitamura, S.; Mori, H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med., 2006, 12, 459-465.
26. Siepe M.; Giraud, M.N.; Liljensten, E.; Nydegger, U.; Menasche, P.; Carrel, T.; Tevaearai, H.T. Construction of skeletal myoblastbased polyurethane scaffolds for myocardial repair. Artif. Organs., 2007, 31, 425-433.
27. Giraud M.N.; Ayuni, E.; Cook, S.; Siepe, M.; Carrel, T.P.; Tevaearai, H.T. Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction. Artif. Organs, 2008, 32, 692-700.
28. Li R.K.; Jia, Z.Q.; Weisel, R.D.; Mickle, D.A.; Choi, A.; Yau, T.M. Survival and function of bioengineered cardiac grafts. Circulation, 1999, 100, II63-69.
29. Leor J.; Aboulafia-Etzion, S.; Dar, A.; Shapiro, L.; Barbash, I.M.; Battler, A.; Granot, Y.; Cohen, S. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation, 2000, 102, III56-61.
30. Dar A.; Shachar, M.; Leor, J.; Cohen, S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol. Bioeng., 2002, 80, 305-312.
31. Kochupura P.V.; Azeloglu, E.U.; Kelly, D.J.; Doronin, S.V.; Badylak, S.F.; Krukenkamp, I.B.; Cohen, I.S.; Gaudette, G.R. Tissueengineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation, 2005, 112, I144-149.
32. Robinson K.A.; Li, J.; Mathison, M.; Redkar, A.; Cui, J.; Chronos, N.A.; Matheny, R.G.; Badylak, S.F. Extracellular matrix scaffold for cardiac repair. Circulation, 2005, 112, I135-143.
33. Zimmermann W.H.; Melnychenko, I.; Wasmeier, G.; Didie, M.; Naito, H.; Nixdorff, U.; Hess, A.; Budinsky, L.; Brune, K.; Michaelis, B.; Dhein, S.; Schwoerer, A.; Ehmke, H.; Eschenhagen, T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med, 2006, 12, 452-458.
34. Okano T.; Yamada, N.; Sakai, H.; Sakurai, Y. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J. Biomed. Mater. Res., 1993, 27, 1243-1251.
35. Lu W.N.; Lu, S.H.; Wang, H.B.; Li, D.X.; Duan, C.M.; Liu, Z.Q.; Hao, T.; He, W.J.; Xu, B.; Fu, Q.; Song, Y.C.; Xie, X.H.; Wang, C.Y. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng. Part. A, 2009, 15, 1437-1447.
36. Shimizu T.; Yamato, M.; Isoi, Y.; Akutsu, T.; Setomaru, T.; Abe, K.; Kikuchi, A.; Umezu, M.; Okano, T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res., 2002, 90, e40.
37. Wei H.J.; Chen, C.H.; Lee, W.Y.; Chiu, I.; Hwang, S.M.; Lin, W.W.; Huang, C.C.; Yeh, Y.C.; Chang, Y.; Sung, H.W. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials, 2008, 29, 3547-3556.
38. Ryu J.H.; Kim, I.K.; Cho, S.W.; Cho, M.C.; Hwang, K.K.; Piao, H.; Piao, S.; Lim, S.H.; Hong, Y.S.; Choi, C.Y.; Yoo, K.J.; Kim, B.S. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials, 2005, 26, 319-326.
39. Kofidis T.; Lebl, D.R.; Martinez, E.C.; Hoyt, G.; Tanaka, M.; Robbins, R.C. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation, 2005, 112, I173-177.
40. Thompson C.A.; Nasseri, B.A.; Makower, J.; Houser, S.; McGarry, M.; Lamson, T.; Pomerantseva, I.; Chang, J.Y.; Gold, H.K.; Vacanti, J.P.; Oesterle, S.N. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J. Am. Coll. Cardiol., 2003, 41, 1964-1971.
41. Christman K.L.; Fok, H.H.; Sievers, R.E.; Fang, Q.; Lee, R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng., 2004, 10, 403-409.
42. Dai W.; Wold, L.E.; Dow, J.S.; Kloner, R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J. Am. Coll. Cardiol., 2005, 46, 714-719.
43. Landa N.; Miller, L.; Feinberg, M.S.; Holbova, R.; Shachar, M.; Freeman, I.; Cohen, S.; Leor, J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation, 2008, 117, 1388-1396.
44. Leor J.; Amsalem, Y.; Cohen, S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Ther., 2005, 105, 151-163.
45. MacLellan W.R.; Schneider, M.D. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol., 2000, 62, 289-319.
46. Linke A.; Muller, P.; Nurzynska, D.; Casarsa, C.; Torella, D.; Nascimbene, A.; Castaldo, C.; Cascapera, S.; Bohm, M.; Quaini, F.; Urbanek, K.; Leri, A.; Hintze, T.H.; Kajstura, J.; Anversa, P. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. USA, 2005, 102, 8966-8971.
47. Urbanek K.; Torella, D.; Sheikh, F.; De Angelis, A.; Nurzynska, D.; Silvestri, F.; Beltrami, C.A.; Bussani, R.; Beltrami, A.P.; Quaini, F.; Bolli, R.; Leri, A.; Kajstura, J.; Anversa, P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. USA, 2005, 102, 8692-8697.
48. Beltrami A.P.; Urbanek, K.; Kajstura, J.; Yan, S.M.; Finato, N.; Bussani, R.; Nadal-Ginard, B.; Silvestri, F.; Leri, A.; Beltrami, C.A.; Anversa, P. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med., 2001, 344, 1750-1757.
49. Anversa P.; Leri, A.; Kajstura, J. Cardiac regeneration. J. Am. Coll. Cardiol., 2006, 47, 1769-1776.
50. Singelyn J.M.; DeQuach, J.A.; Seif-Naraghi, S.B.; Littlefield, R.B.; Schup-Magoffin, P.J.; Christman, K.L. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials, 2009, 30, 5409-5416.
51. Mihardja S.S.; Sievers, R.E.; Lee, R.J. The effect of polypyrrole on arteriogenesis in an acute rat infarct model. Biomaterials, 2008, 29, 4205-4210.
52. Davis M.E.; Motion, J.P.; Narmoneva, D.A.; Takahashi, T.; Hakuno, D.; Kamm, R.D.; Zhang, S.; Lee, R.T. Injectable selfassembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation, 2005, 111, 442-450.
53. Yu J.; Gu, Y.; Du, K.T.; Mihardja, S.; Sievers, R.E.; Lee, R.J. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials, 2009, 30, 751-756.
54. Lin Y.D.; Yeh, M.L.; Yang, Y.J.; Tsai, D.C.; Chu, T.Y.; Shih, Y.Y.; Chang, M.Y.; Liu, Y.W.; Tang, A.C.; Chen, T.Y.; Luo, C.Y.; Chang, K.C.; Chen, J.H.; Wu, H.L.; Hung, T.K.; Hsieh, P.C. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation, 2010, 122, S132-141.
55. Young S.; Wong, M.; Tabata, Y.; Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release, 2005, 109, 256-274.
56. Holland T.A.; Tabata, Y.; Mikos, A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J. Control. Release, 2005, 101, 111-125.
57. Park H.; Temenoff, J.S.; Tabata, Y.; Caplan, A.I.; Mikos, A.G. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials, 2007, 28, 3217-3227.
58. Iwakura A.; Fujita, M.; Kataoka, K.; Tambara, K.; Sakakibara, Y.; Komeda, M.; Tabata, Y. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart. Vessels, 2003, 18, 93-99.
59. Christman K.L.; Fang, Q.; Yee, M.S.; Johnson, K.R.; Sievers, R.E.; Lee, R.J. Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials, 2005, 26, 1139-1144.
60. Hsieh P.C.; Davis, M.E.; Gannon, J.; MacGillivray, C.; Lee, R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest., 2006, 116, 237-248.
61. Agathopoulos S.; Nikolopoulos, P. Wettability and interfacial interactions in bioceramic-body-liquid systems. J. Biomed. Mater. Res., 1995, 29, 421-429.
62. Gournis D.; Deligiannakis, Y.; Karakassides, M.A.; Boussac, A.; Ioannidis, N.; Petridis, D. Stability study of tyrosinate radical in a restricted phyllomorphous medium. Langmuir, 2002, 18, 10024-10029.
63. Gournis D.; Georgakilas, V.; Karakassides, M.A.; Bakas, T.; Kordatos, K.; Prato, M.; Fanti, M.; Zerbetto, F. Incorporation of fullerene derivatives into smectite clays: a new family of organicinorganic nanocomposites. J. Am. Chem. Soc., 2004, 126, 8561-8568.
64. Gournis D.; Jankovic, L.; Maccallini, E.; Benne, D.; Rudolf, P.; Colomer, J.F.; Sooambar, C.; Georgakilas, V.; Prato, M.; Fanti, M.; Zerbetto, F.; Sarova, G.H.; Guldi, D.M. Clay-fulleropyrrolidine nanocomposites. J. Am. Chem. Soc., 2006, 128, 6154-6163.
65. Bourlinos A.; Karakassides, M.A.; Petridis, D. Synthesis and characterization of hollow clay microspheres through a resin template approach. Chem. Commun., 2001, 16, 1518-1519.
66. Serefoglou E.; Litina, K.; Gournis, D.; Kalogeris, E.; Tzialla, A.A.; Pavlidis, I.V.; Stamatis, C.; Maccallini, E.; Lubomska, M.; Rudolf, P. Smectite clays as solid supports for immobilization of β-glucosidase: Synthesis, Characterization and Biochemical properties. Chem. Mater., 2008, 20, 4106-4115.
67. Ruvinov E.; Leor, J.; Cohen, S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials, 2011, 32, 565-578.
68. Anderson J.M.; Rodriguez, A.; Chang, D.T. Foreign body reaction to biomaterials. Semin. Immunol., 2008, 20, 86-100.
69. Yang S.C.; Bhide, M.; Crispe, I.N.; Pierce, R.H.; Murthy, N. Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. Bioconjug. Chem., 2008, 19, 1164-1169.
70. Frangogiannis N.G. Targeting the inflammatory response in healing myocardial infarcts. Curr. Med. Chem., 2006, 13, 1877-1893.
71. Sy J.C.; Seshadri, G.; Yang, S.C.; Brown, M.; Oh, T.; Dikalov, S.; Murthy, N.; Davis, M.E. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat. Mater., 2008, 7, 863-868.
72. Li Z.; Ma, J.Y.; Kerr, I.; Chakravarty, S.; Dugar, S.; Schreiner, G.; Protter, A.A. Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury. Am. J. Physiol. Heart Circ. Physiol., 2006, 291, H1972-1977.
73. Shin H.; Jo, S.; Mikos, A.G. Biomimetic materials for tissue engineering. Biomaterials, 2003, 24, 4353-4364.